Evolution of the Present Understanding of the Clinical and Genetic Heterogeneity and Molecular and Biochemical Basis of Osteogenesis Imperfecta - Osteogenesis Imperfecta - page 11

[51] Myllyharju J, Kivirikko KI. Collagens, modifying enzymes and

their mutations in humans, lies and worms. Trends in Genetics:
TIG 2004;20(1):33-43.

[65] Smith R, Francis MJ, Houghton GR. The brittle bone syndrome.
London: Butterworths; 1983.
[66] Smars G. Osteogenesis Imperfecta in Sweden. Clinical, Genetic,
Epidemiological and Socio-medical Aspects. Stockholm:
Scandinavian University Books; 1961.
[67] Garretsen AJ. Osteogenesis imperfecta type I. Otological and
clinical genetics aspects. University of Nijmegen; 1992.
[68] Kuurila K. Hearing loss balance problems and molecular defects
in osteogenesis imperfecta - A nationwide study in Finland.
Turku Finland: University of Turku; 2003.
[69] Waltimo J. Developmental defects of human dentin matrix - An
ultrastructural study. Finland: Helsinki: University of Helsinki;
1996.
[70] Malmgren B, Lindskog S, Elgadi A, Norgren S. Clinical, histo-
pathologic, and genetic investigation in two large families with
dentinogenesis imperfecta type II. Hum Genet 2004;114(5):491-8.
[71] Engelbert R. Osteogenesis imperfecta in childhood. Clinical and
functional characteristics. University of Utrecht; 1996.
[72] Sillence D. Bone dysplasia: genetic and ultrastructural studies
with special reference to osteogenesis imperfecta. Ann Arbor,
Michigan USA: University Microilms International; 1980.
[73] Lamande SR. Molecular analysis of naturally occurring and
engineered collagen mutations. Parkville Victoria Australia:
University of Melbourne; 1994.
[74] Van Dijk FS. Osteogenesis imperfecta - clinical and genetic het-
erogeneity. University Medical Centre Amsterdam Netherlands;
2011.
[75] Van Dijk FS, Byers PH, Dalgleish R, Malfait F, Maugeri A,
Rohrbach M, et al. EMQN best practice guidelines for the labo-
ratory diagnosis of osteogenesis imperfecta. Eur J Hum Genet
2012;20(1):11-19.
[76] Glorieux FH, Bishop NJ, Plotkin H, Chabot G, Lanoue G,
Travers R. Cyclic administration of pamidronate in chil-
dren with severe osteogenesis imperfecta. N Engl J Med
1998;339(14):947-52.
[77] Shaheen R, Alazami AM, Alshammari MJ, Faqeih E, Alhashmi
N, Mousa N, et al. Study of autosomal recessive osteogenesis
imperfecta in Arabia reveals a novel locus deined by TMEM38B
mutation. J Med Genet 2012;49(10):630-5.
[78] Pyott SM, Tran TT, Leistritz DF, Pepin MG, Mendelsohn NJ,
Temme RT, et al. WNT1 mutations in families affected by mod-
erately severe and progressive recessive osteogenesis imper-
fecta. Am J Hum Genet 2013;92(4):590-7.
[79] Keupp K, Beleggia F, Kayserili H, Barnes AM, Steiner M, Semler
O, et al. Mutations in WNT1 cause different forms of bone fra-
gility. Am J Hum Genet 2013;92(4):565-74.
[80] Fahiminiya S, Majewski J, Mort J, Moffatt P, Glorieux FH, Rauch
F. Mutations in WNT1 are a cause of osteogenesis imperfecta. J
Med Genet 2013;50(5):345-8.

[52] Morello R, Bertin TK, Chen Y, Hicks J, Tonachini L, Monticone

M, et al. CRTAP is required for prolyl 3-hydroxylation and
mutations cause recessive osteogenesis imperfecta. Cell
2006;127(2):291-304.

[53] Lamande SR, Bateman JF. Procollagen folding and assembly: the

role of endoplasmic reticulum enzymes and molecular chaper-
ones. Semin Cell Dev Biol 1999;10(5):455-64.

[54] Alanay Y, Avaygan H, Camacho N, Utine GE, Boduroglu K,

Aktas D, et al. Mutations in the gene encoding the RER protein
FKBP65 cause autosomal-recessive osteogenesis imperfecta. Am
J Hum Genet 2010;87(4):572-3.

[55] Becker J, Semler O, Gilissen C, Li Y, Bolz HJ, Giunta C, et al.

Exome sequencing identiies truncating mutations in human
SERPINF1 in autosomal-recessive osteogenesis imperfecta. Am
J Hum Genet 2011;88(3):362-71.

[56] van Dijk FS, Nesbitt IM, Zwikstra EH, Nikkels PG, Piersma SR,

Fratantoni SA, et al. PPIB mutations cause severe osteogenesis
imperfecta. Am J Hum Genet 2009;85(4):521-7.

[57] Lapunzina P, Aglan M, Temtamy S, Caparros-Martin JA,

Valencia M, Leton R, et al. Identiication of a frameshift muta-
tion in Osterix in a patient with recessive osteogenesis imper-
fecta. Am J Hum Genet 2010;87(1):110-4.

[58] Semler O, Garbes L, Keupp K, Swan D, Zimmermann K, Becker

J, et al. A mutation in the 5′-UTR of IFITM5 creates an in-frame
start codon and causes autosomal-dominant osteogenesis
imperfecta type V with hyperplastic callus. Am J Hum Genet
2012;91(2):349-57.

[59] Cho TJ, Lee KE, Lee SK, Song SJ, Kim KJ, Jeon D, et al. A single

recurrent mutation in the 5′-UTR of IFITM5 causes osteogenesis
imperfecta type V. Am J Hum Genet 2012;91(2):343-8.

[60] Asharani PV, Keupp K, Semler O, Wang W, Li Y, Thiele H, et al.

Attenuated BMP1 function compromises osteogenesis, lead-
ing to bone fragility in humans and zebraish. Am J Hum Genet
2012;90(4):661-74.

[61] Lindahl K, Barnes AM, Fratzl-Zelman N, Whyte MP, Hefferan

TE, Makareeva E, et al. COL1 C-propeptide cleavage site muta-
tions cause high bone mass osteogenesis imperfecta. Hum
Mutat 2011;32(6):598-609.

[62] Martinez-Glez V, Valencia M, Caparros-Martin JA, Aglan M,

Temtamy S, Tenorio J, et al. Identiication of a mutation causing
deicient BMP1/mTLD proteolytic activity in autosomal reces-
sive osteogenesis imperfecta. Hum Mutat 2012;33(2):343-50.

[63] van Dijk FS, Huizer M, Kariminejad A, Marcelis CL, Plomp AS,

Terhal PA, et al. Complete COL1A1 allele deletions in osteogen-
esis imperfecta. Genet Med 2010;12(11):736-41.

[64] Emery SC, Karpinski NC, Hansen L, Masliah E. Abnormalities

in central nervous system development in osteogenesis imper-
fecta type II. Pediatr Dev Pathol 1999;2(2):124-30.